NCT07131059 2025-08-20
MRD-positive AML Clinical Study
Institute of Hematology & Blood Diseases Hospital, China
Phase NA Recruiting
Clinical Trials
8 trialsNCT06697327 2025-05-14
Daunorubicin + Cytarabine + Venetoclax in de Novo AML
Anhui Medical University
Phase NA Enrolling by invitation
NCT05832320 2024-05-10
Optimum Induction Therapy of Low-risk APL
Peking University People's Hospital
Phase NA Recruiting
NCT01156883 2021-09-13
LAL1308
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase NA Completed
NCT01953770 2020-02-05
ALL-MB 2008
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase NA Unknown
NCT00550992 2019-07-30
Interfant06
Dutch Childhood Oncology Group
Phase NA Unknown
NCT00187057 2015-08-27
Study for Treatment of Cancer in Children With Ataxia-telangiectasia
St. Jude Children's Research Hospital
Phase NA Completed
NCT00537550 2007-10-01
LAL2000
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase NA Completed